Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models
Year: 2019
Type: review
Source: Nature Reviews Drug Discovery
Authors: Richard J. Weaver, Eric A. Blomme, Amy E. Chadwick, Ian M. Copple, Helga H. J. Gerets, Christopher E. Goldring, Andre Guillouzo, Philip G. Hewitt, Magnus Ingelman-Sundberg, Klaus Gjervig Jensen, Satu Juhila, Ursula Klingmüller, Gilles Labbe, Michael J. Liguori, Cerys A. Lovatt, Paul Morgan, Dean J. Naisbitt, Raymond H. H. Pieters, Jan Snoeys, Bob van de Water, Dominic P. Williams, B. Kevin Park
Institutions: Institut de Recherches Internationales Servier (France), AbbVie (United States), University of Liverpool, UCB Pharma (Belgium), Inserm, Nutrition, métabolismes et cancer, Université de Rennes, Merck KGaA, Darmstadt (Germany), Merck Healthcare KGaA, Darmstadt (Germany), Karolinska Institutet, Lundbeck (Denmark), Orion Corporation (Finland), German Cancer Research Center, Sanofi (France), GlaxoSmithKline (United Kingdom), AstraZeneca (United Kingdom), Utrecht University, Janssen (Belgium), Leiden University
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2991137874
